D. Christopher Radford

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Inhibition of Immunosuppressive Tumors by Polymer‐Assisted Inductions of Immunogenic Cell Death and Multivalent PD‐L1 Crosslinking”.

Inhibition of Immunosuppressive Tumors by Polymer‐Assisted Inductions of Immunogenic Cell Death and Multivalent PD‐L1 Crosslinking

Advanced Functional Materials(2020)10.1002/adfm.201908961

N/A

0DataRank · unranked

116 citations

Yachao Li, Chieh‐Hsiang Yang, D. Christopher Radford, Jiawei Wang, Margit Janát‐Amsbury +3 more

Combination treatment with immunogenic and anti-PD-L1 polymer-drug conjugates of advanced tumors in a transgenic MMTV-PyMT mouse model of breast cancer

Journal of Controlled Release(2021)10.1016/j.jconrel.2021.02.011

N/A

0DataRank · unranked

20 citations

Jiawei Wang, D. Christopher Radford, Jindŕich Kopec̆ek, Jiyuan Yang, Lian Li

Simultaneous crosslinking of CD20 and CD38 receptors by drug-free macromolecular therapeutics enhances B cell apoptosis in vitro and in vivo

Journal of Controlled Release(2022)10.1016/j.jconrel.2022.08.045

N/A

0DataRank · unranked

17 citations

Jiahui Li, D. Christopher Radford, Douglas W. Sborov, Paul J. Shami, Jiyuan Yang +2 more